Skip to content

GlobalLawDBby GenieAI

Laws Search Sanctions Map Data Developers

Search the text of the law

Log in Get an API key

Laws Search Sanctions Map Data Developers

Log in Get an API key

The Global Law Database. Free to read, built for people and AI agents.

Explore

All laws
Search the text
Sanctions
Map of connections
Compare UK and EU

Developers

AI agents (MCP)
REST API
Bulk data
API keys

Coverage

United Kingdom
European Union
United States
Canada
Australia
France
Germany
Netherlands
Spain
Austria
Norway
Finland
Switzerland
Ireland

GlobalLawDB is made by GenieAI, London. It is not legal advice: check the official text before relying on it. Text comes from official publishers under their licences, listed on the Data page.

ThemeMatch my systemLightDark

Australia
National Health (Weighted average disclosed price – October 2026 reduction day) Amendment Determination 2026

National Health (Weighted average disclosed price – October 2026 reduction day) Amendment Determination 2026

law://au/li/2026/f2026l01150@2026-11-13

Version in force onWhereAustralia

History · 1 version

3 Sept 2026Reading

Key facts

Type: Legislative instrument · F2026L01150
Made: 31 Aug 2026
Text current to: 3 Sept 2026
Official: Federal Register of Legislation

This text since 3 Sept 2026

In force

PB 97 of 2026 #

National Health (Weighted average disclosed price – October 2026 reduction day) Amendment Determination 2026 #

I, Mike Pope, Assistant Secretary, PBS Listing, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 99ADB(4) of the National Health Act 1953.Dated: 31 August 2026Mike PopeAssistant SecretaryPBS Listing, Pricing and Policy BranchTechnology Assessment and Access DivisionDepartment of Health, Disability and Ageing

1 Name of Instrument #

This instrument is the National Health (Weighted average disclosed price – October 2026 reduction day) Amendment Determination 2026.This instrument may also be cited as PB 97 of 2026.

2 Commencement #

This instrument commences on the day after it is registered.

3 Authority #

This instrument is made under subsection 99ADB(4) of the National Health Act 1953.

4 Schedules #

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.Schedule 1 AmendmentsNational Health (Weighted average disclosed price – October 2026 reduction day) Determination 2026 (PB 72 of 2026)Schedule 1omit:28 | Adalimumab | Injection 80 mg in 0.8 mL pre-filled pen | Injection | Humira | 546.9829 | Adalimumab | Injection 80 mg in 0.8 mL pre-filled pen | Injection | Hyrimoz | 546.9830 | Adalimumab | Injection 80 mg in 0.8 mL pre-filled pen | Injection | Yuflyma | 546.98Schedule 1omit:31 | Atomoxetine | Capsule 10 mg (as hydrochloride) | Oral | APO-Atomoxetine | 25.0432 | Atomoxetine | Capsule 10 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 25.0433 | Atomoxetine | Capsule 18 mg (as hydrochloride) | Oral | APO-Atomoxetine | 25.0434 | Atomoxetine | Capsule 18 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 25.0435 | Atomoxetine | Capsule 25 mg (as hydrochloride) | Oral | APO-Atomoxetine | 25.0436 | Atomoxetine | Capsule 25 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 25.0437 | Atomoxetine | Capsule 40 mg (as hydrochloride) | Oral | APO-Atomoxetine | 25.0438 | Atomoxetine | Capsule 40 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 25.0439 | Atomoxetine | Capsule 60 mg (as hydrochloride) | Oral | APO-Atomoxetine | 25.0440 | Atomoxetine | Capsule 60 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 25.0441 | Atomoxetine | Capsule 80 mg (as hydrochloride) | Oral | APO-Atomoxetine | 32.5642 | Atomoxetine | Capsule 80 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 32.56Schedule 1omit:45 | Azathioprine | Tablet 25 mg | Oral | APO-Azathioprine | 6.8746 | Azathioprine | Tablet 25 mg | Oral | AZATHIOPRINE-WGR | 6.8747 | Azathioprine | Tablet 25 mg | Oral | Azathioprine Sandoz | 6.8748 | Azathioprine | Tablet 25 mg | Oral | Imuran | 6.8749 | Azathioprine | Tablet 50 mg | Oral | APO-Azathioprine | 11.750 | Azathioprine | Tablet 50 mg | Oral | AZATHIOPRINE-WGR | 11.751 | Azathioprine | Tablet 50 mg | Oral | Azapin | 11.752 | Azathioprine | Tablet 50 mg | Oral | Azathioprine Sandoz | 11.753 | Azathioprine | Tablet 50 mg | Oral | Imazan | 11.754 | Azathioprine | Tablet 50 mg | Oral | Imuran | 11.755 | Azathioprine | Tablet 50 mg | Oral | Thioprine 50 | 11.7Schedule 1omit:66 | Buprenorphine | Transdermal patch 10 mg | Transdermal | B-Patch | 10.9967 | Buprenorphine | Transdermal patch 10 mg | Transdermal | Bupredermal | 10.9968 | Buprenorphine | Transdermal patch 10 mg | Transdermal | Buprenorphine Sandoz | 10.9969 | Buprenorphine | Transdermal patch 10 mg | Transdermal | Norspan | 10.9970 | Buprenorphine | Transdermal patch 15 mg | Transdermal | B-Patch | 13.9771 | Buprenorphine | Transdermal patch 15 mg | Transdermal | Bupredermal | 13.9772 | Buprenorphine | Transdermal patch 15 mg | Transdermal | Buprenorphine Sandoz | 13.9773 | Buprenorphine | Transdermal patch 15 mg | Transdermal | Norspan | 13.9774 | Buprenorphine | Transdermal patch 20 mg | Transdermal | B-Patch | 16.9575 | Buprenorphine | Transdermal patch 20 mg | Transdermal | Bupredermal | 16.9576 | Buprenorphine | Transdermal patch 20 mg | Transdermal | Buprenorphine Sandoz | 16.9577 | Buprenorphine | Transdermal patch 20 mg | Transdermal | Norspan | 16.9578 | Buprenorphine | Transdermal patch 25 mg | Transdermal | Bupredermal | 19.7779 | Buprenorphine | Transdermal patch 25 mg | Transdermal | Buprenorphine Sandoz | 19.7780 | Buprenorphine | Transdermal patch 25 mg | Transdermal | Norspan | 19.7781 | Buprenorphine | Transdermal patch 30 mg | Transdermal | Bupredermal | 22.5982 | Buprenorphine | Transdermal patch 30 mg | Transdermal | Buprenorphine Sandoz | 22.5983 | Buprenorphine | Transdermal patch 30 mg | Transdermal | Norspan | 22.5984 | Buprenorphine | Transdermal patch 40 mg | Transdermal | Bupredermal | 28.2585 | Buprenorphine | Transdermal patch 40 mg | Transdermal | Buprenorphine Sandoz | 28.2586 | Buprenorphine | Transdermal patch 40 mg | Transdermal | Norspan | 28.2587 | Buprenorphine | Transdermal patch 5 mg | Transdermal | B-Patch | 6.188 | Buprenorphine | Transdermal patch 5 mg | Transdermal | Bupredermal | 6.189 | Buprenorphine | Transdermal patch 5 mg | Transdermal | Buprenorphine Sandoz | 6.190 | Buprenorphine | Transdermal patch 5 mg | Transdermal | Norspan | 6.1Schedule 1omit:97 | Ceftriaxone | Powder for injection 1 g (as sodium) | Injection | Ceftriaxone Viatris | 19.7298 | Ceftriaxone | Powder for injection 2 g (as sodium) | Injection | Ceftriaxone Viatris | 9.94Schedule 1omit:137 | Deferasirox | Tablet 180 mg | Oral | DEFERAMED | 18.34138 | Deferasirox | Tablet 180 mg | Oral | DEFERASIROX-TEVA | 18.34139 | Deferasirox | Tablet 180 mg | Oral | Deferasirox ARX | 18.34140 | Deferasirox | Tablet 180 mg | Oral | Deferasirox Sandoz | 18.34141 | Deferasirox | Tablet 180 mg | Oral | Eferas | 18.34142 | Deferasirox | Tablet 180 mg | Oral | Jadenu | 18.34143 | Deferasirox | Tablet 180 mg | Oral | Pharmacor Deferasirox FC | 18.34144 | Deferasirox | Tablet 360 mg | Oral | DEFERAMED | 36.68145 | Deferasirox | Tablet 360 mg | Oral | DEFERASIROX-TEVA | 36.68146 | Deferasirox | Tablet 360 mg | Oral | Deferasirox ARX | 36.68147 | Deferasirox | Tablet 360 mg | Oral | Deferasirox Sandoz | 36.68148 | Deferasirox | Tablet 360 mg | Oral | Eferas | 36.68149 | Deferasirox | Tablet 360 mg | Oral | Jadenu | 36.68150 | Deferasirox | Tablet 360 mg | Oral | Pharmacor Deferasirox FC | 36.68151 | Deferasirox | Tablet 90 mg | Oral | DEFERAMED | 9.17152 | Deferasirox | Tablet 90 mg | Oral | DEFERASIROX-TEVA | 9.17153 | Deferasirox | Tablet 90 mg | Oral | Deferasirox ARX | 9.17154 | Deferasirox | Tablet 90 mg | Oral | Deferasirox Sandoz | 9.17155 | Deferasirox | Tablet 90 mg | Oral | Eferas | 9.17156 | Deferasirox | Tablet 90 mg | Oral | Jadenu | 9.17157 | Deferasirox | Tablet 90 mg | Oral | Pharmacor Deferasirox FC | 9.17Schedule 1omit:199 | Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | FULVESTRANT ACCORD | 113.82200 | Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | FULVESTRANT EVER PHARMA | 113.82201 | Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | FULVESTRANT-AFT | 113.82202 | Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | Fulvestrant SXP | 113.82203 | Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | Fulvestrant Sandoz | 113.82Schedule 1omit:237 | Lacosamide | Tablet 100 mg | Oral | Lacosam | 9.73238 | Lacosamide | Tablet 100 mg | Oral | Lacosamide ARX | 9.73239 | Lacosamide | Tablet 100 mg | Oral | Lacosamide Lupin | 9.73240 | Lacosamide | Tablet 100 mg | Oral | Lacosamide Sandoz | 9.73241 | Lacosamide | Tablet 100 mg | Oral | Lacosamide Sandoz | 9.73242 | Lacosamide | Tablet 100 mg | Oral | Vimcosa | 9.73243 | Lacosamide | Tablet 100 mg | Oral | Vimcosa | 9.73244 | Lacosamide | Tablet 100 mg | Oral | Vimpat | 9.73245 | Lacosamide | Tablet 100 mg | Oral | Vimpat | 9.73246 | Lacosamide | Tablet 150 mg | Oral | Lacosam | 14.59247 | Lacosamide | Tablet 150 mg | Oral | Lacosamide ARX | 14.59248 | Lacosamide | Tablet 150 mg | Oral | Lacosamide Lupin | 14.59249 | Lacosamide | Tablet 150 mg | Oral | Lacosamide Sandoz | 14.59250 | Lacosamide | Tablet 150 mg | Oral | Vimcosa | 14.59251 | Lacosamide | Tablet 150 mg | Oral | Vimcosa | 14.59252 | Lacosamide | Tablet 150 mg | Oral | Vimpat | 14.59253 | Lacosamide | Tablet 150 mg | Oral | Vimpat | 14.59254 | Lacosamide | Tablet 200 mg | Oral | Lacosam | 77.8255 | Lacosamide | Tablet 200 mg | Oral | Lacosamide ARX | 77.8256 | Lacosamide | Tablet 200 mg | Oral | Lacosamide Lupin | 77.8257 | Lacosamide | Tablet 200 mg | Oral | Lacosamide Sandoz | 77.8258 | Lacosamide | Tablet 200 mg | Oral | Vimcosa | 77.8259 | Lacosamide | Tablet 200 mg | Oral | Vimpat | 77.8260 | Lacosamide | Tablet 50 mg | Oral | Lacosam | 4.86237 | Lacosamide | Tablet 50 mg | Oral | Lacosamide ARX | 4.86238 | Lacosamide | Tablet 50 mg | Oral | Lacosamide Lupin | 4.86239 | Lacosamide | Tablet 50 mg | Oral | Lacosamide Sandoz | 4.86240 | Lacosamide | Tablet 50 mg | Oral | Vimcosa | 4.86241 | Lacosamide | Tablet 50 mg | Oral | Vimpat | 4.86Schedule 1omit:261 | Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | APO-Latanoprost/Timolol 0.05/5 | 5.96262 | Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | Xalacom | 5.96263 | Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | Xalamol 50/5 | 5.96Schedule 1omit:430 | Sitagliptin with metformin | Tablet (modified release) containing 100 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Janumet XR | 23.09431 | Sitagliptin with metformin | Tablet (modified release) containing 100 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Sandoz XR | 23.09432 | Sitagliptin with metformin | Tablet (modified release) containing 100 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Sitagliptin/Metformin XR Mylan | 23.09433 | Sitagliptin with metformin | Tablet (modified release) containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Janumet XR | 23.86434 | Sitagliptin with metformin | Tablet (modified release) containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Sandoz XR | 23.86435 | Sitagliptin with metformin | Tablet (modified release) containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Sitagliptin/Metformin XR Mylan | 23.86436 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Janumet | 16.69437 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | SITAGLIPTIN/METFORMIN 50/1000 SUN | 16.69438 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | SITAGLO-MET | 16.69439 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Mylan 50/1000 | 16.69440 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Sandoz | 16.69441 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Velmetia | 16.69442 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride | Oral | Janumet | 15.92443 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride | Oral | SITAGLIPTIN/METFORMIN 50/500 SUN | 15.92444 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride | Oral | SITAGLO-MET | 15.92445 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Mylan 50/500 | 15.92446 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Sandoz | 15.92447 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride | Oral | Velmetia | 15.92448 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride | Oral | Janumet | 16.46449 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride | Oral | SITAGLIPTIN/METFORMIN 50/850 SUN | 16.46450 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride | Oral | SITAGLO-MET | 16.46451 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Mylan 50/850 | 16.46452 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Sandoz | 16.46453 | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride | Oral | Velmetia | 16.46Schedule 1omit:454 | Tacrolimus | Capsule 0.5 mg (once daily prolonged release) | Oral | ADVAGRAF XL | 31.67455 | Tacrolimus | Capsule 0.5 mg (once daily prolonged release) | Oral | Tacrolimus XR Sandoz | 31.67Schedule 1omit:468 | Valganciclovir | Tablet 450 mg (as hydrochloride) | Oral | Valganciclovir Sandoz | 195.35469 | Valganciclovir | Tablet 450 mg (as hydrochloride) | Oral | Valganciclovir Viatris | 195.35Schedule 1omit:470 | Vancomycin | Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) | Injection | VANCOMYCIN MEDSURGE | 4.95471 | Vancomycin | Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) | Injection | Vancomycin Juno | 4.95472 | Vancomycin | Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) | Injection | Vancomycin Viatris | 4.95Schedule 1omit:473 | Varenicline | Box containing 11 tablets 0.5 mg and 42 tablets 1 mg | Oral | Champix | 31.92474 | Varenicline | Box containing 11 tablets 0.5 mg and 42 tablets 1 mg | Oral | PHARMACOR VARENICLINE | 31.92475 | Varenicline | Box containing 11 tablets 0.5 mg and 42 tablets 1 mg | Oral | VARENAPIX | 31.92476 | Varenicline | Box containing 11 tablets 0.5 mg and 42 tablets 1 mg | Oral | Varenicline Lupin | 31.92477 | Varenicline | Box containing 11 tablets 0.5 mg and 42 tablets 1 mg | Oral | Varenicline Sandoz | 31.92478 | Varenicline | Box containing 11 tablets 0.5 mg and 42 tablets 1 mg | Oral | Varenicline Viatris | 31.92479 | Varenicline | Tablet 1 mg | Oral | Champix | 37.63480 | Varenicline | Tablet 1 mg | Oral | PHARMACOR VARENICLINE | 37.63481 | Varenicline | Tablet 1 mg | Oral | VARENAPIX | 37.63482 | Varenicline | Tablet 1 mg | Oral | Varenicline Lupin | 37.63473 | Varenicline | Tablet 1 mg | Oral | Varenicline Sandoz | 37.63474 | Varenicline | Tablet 1 mg | Oral | Varenicline Viatris | 37.63Schedule 2after: 33 | Adalimumab | Injection 40 mg in 0.4 mL pre-filled syringe | Injection | Yuflyma | 444.17insert:33A | Adalimumab | Injection 80 mg in 0.8 mL pre-filled pen | Injection | Humira | 546.9833B | Adalimumab | Injection 80 mg in 0.8 mL pre-filled pen | Injection | Hyrimoz | 546.9833C | Adalimumab | Injection 80 mg in 0.8 mL pre-filled pen | Injection | Yuflyma | 546.98Schedule 2after:45 | Adrenaline (epinephrine) | Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000) | Injection | Link Medical Products Pty Ltd | 7.11insert:45A | Adrenaline (epinephrine) | Nasal spray device 1 mg in 1 actuation | Nasal | neffy | 142.3545B | Adrenaline (epinephrine) | Nasal spray device 2 mg in 1 actuation | Nasal | neffy | 142.35Schedule 2after:279 | Atenolol | Tablet 50 mg | Oral | Tensig | 4.00insert:279A | Atomoxetine | Capsule 10 mg (as hydrochloride) | Oral | APO-Atomoxetine | 25.04279B | Atomoxetine | Capsule 10 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 25.04279C | Atomoxetine | Capsule 18 mg (as hydrochloride) | Oral | APO-Atomoxetine | 25.04279D | Atomoxetine | Capsule 18 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 25.04279E | Atomoxetine | Capsule 25 mg (as hydrochloride) | Oral | APO-Atomoxetine | 25.04279F | Atomoxetine | Capsule 25 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 25.04279G | Atomoxetine | Capsule 40 mg (as hydrochloride) | Oral | APO-Atomoxetine | 25.04279H | Atomoxetine | Capsule 40 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 25.04279I | Atomoxetine | Capsule 60 mg (as hydrochloride) | Oral | APO-Atomoxetine | 25.04279J | Atomoxetine | Capsule 60 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 25.04279K | Atomoxetine | Capsule 80 mg (as hydrochloride) | Oral | APO-Atomoxetine | 32.56279L | Atomoxetine | Capsule 80 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 32.56Schedule 2after:332 | Azacitidine | Tablet 300 mg | Oral | Onureg | 6613.88insert:332A | Azathioprine | Tablet 25 mg | Oral | APO-Azathioprine | 6.87332B | Azathioprine | Tablet 25 mg | Oral | AZATHIOPRINE-WGR | 6.87332C | Azathioprine | Tablet 25 mg | Oral | Azathioprine Sandoz | 6.87332D | Azathioprine | Tablet 25 mg | Oral | Imuran | 6.87332E | Azathioprine | Tablet 50 mg | Oral | APO-Azathioprine | 11.7332F | Azathioprine | Tablet 50 mg | Oral | AZATHIOPRINE-WGR | 11.7332G | Azathioprine | Tablet 50 mg | Oral | Azapin | 11.7332H | Azathioprine | Tablet 50 mg | Oral | Azathioprine Sandoz | 11.7332I | Azathioprine | Tablet 50 mg | Oral | Imazan | 11.7332J | Azathioprine | Tablet 50 mg | Oral | Imuran | 11.7332K | Azathioprine | Tablet 50 mg | Oral | Thioprine 50 | 11.7Schedule 2after:464 | Buprenorphine | Tablet (sublingual) 8 mg (as hydrochloride) | Sublingual | Subutex | 23.99insert:464A | Buprenorphine | Transdermal patch 10 mg | Transdermal | B-Patch | 10.99464B | Buprenorphine | Transdermal patch 10 mg | Transdermal | Bupredermal | 10.99464C | Buprenorphine | Transdermal patch 10 mg | Transdermal | Buprenorphine Sandoz | 10.99464D | Buprenorphine | Transdermal patch 10 mg | Transdermal | Norspan | 10.99464E | Buprenorphine | Transdermal patch 15 mg | Transdermal | B-Patch | 13.97464F | Buprenorphine | Transdermal patch 15 mg | Transdermal | Bupredermal | 13.97464G | Buprenorphine | Transdermal patch 15 mg | Transdermal | Buprenorphine Sandoz | 13.97464H | Buprenorphine | Transdermal patch 15 mg | Transdermal | Norspan | 13.97464I | Buprenorphine | Transdermal patch 20 mg | Transdermal | B-Patch | 16.95464J | Buprenorphine | Transdermal patch 20 mg | Transdermal | Bupredermal | 16.95464K | Buprenorphine | Transdermal patch 20 mg | Transdermal | Buprenorphine Sandoz | 16.95464L | Buprenorphine | Transdermal patch 20 mg | Transdermal | Norspan | 16.95464M | Buprenorphine | Transdermal patch 25 mg | Transdermal | Bupredermal | 19.77464N | Buprenorphine | Transdermal patch 25 mg | Transdermal | Buprenorphine Sandoz | 19.77464O | Buprenorphine | Transdermal patch 25 mg | Transdermal | Norspan | 19.77464P | Buprenorphine | Transdermal patch 30 mg | Transdermal | Bupredermal | 22.59464Q | Buprenorphine | Transdermal patch 30 mg | Transdermal | Buprenorphine Sandoz | 22.59464R | Buprenorphine | Transdermal patch 30 mg | Transdermal | Norspan | 22.59464S | Buprenorphine | Transdermal patch 40 mg | Transdermal | Bupredermal | 28.25464T | Buprenorphine | Transdermal patch 40 mg | Transdermal | Buprenorphine Sandoz | 28.25464U | Buprenorphine | Transdermal patch 40 mg | Transdermal | Norspan | 28.25464V | Buprenorphine | Transdermal patch 5 mg | Transdermal | B-Patch | 6.1464W | Buprenorphine | Transdermal patch 5 mg | Transdermal | Bupredermal | 6.1464X | Buprenorphine | Transdermal patch 5 mg | Transdermal | Buprenorphine Sandoz | 6.1464Y | Buprenorphine | Transdermal patch 5 mg | Transdermal | Norspan | 6.1Schedule 2after:598 | Ceftriaxone | Powder for injection 500 mg (as sodium) | Injection | Ceftriaxone-AFT | 4.00insert:598A | Ceftriaxone | Powder for injection 1 g (as sodium) | Injection | Ceftriaxone Viatris | 19.72598B | Ceftriaxone | Powder for injection 2 g (as sodium) | Injection | Ceftriaxone Viatris | 9.94Schedule 2after:735 | Cyclophosphamide | Powder for injection 2 g (anhydrous) | Injection | Endoxan | 29.30insert:735A | Cyclophosphamide | Powder for injection 1 g (NorthStar, USA) (s19A) | Injection | Cyclophosphamide (NorthStar, USA) | 314.63735B | Cyclophosphamide | Powder for injection 2 g (NorthStar, USA) (s19A) | Injection | Cyclophosphamide (NorthStar, USA) | 584.18735C | Cyclophosphamide | Powder for injection 2 g (Sagent, USA) (s19A) | Injection | Cyclophosphamide (Sagent, USA) | 422.64Schedule 2after:756 | Dapsone | Tablet 25 mg | Oral | Link Medical Products Pty Ltd | 263.68insert:756A | Dapsone | Tablet 25 mg (s19A) | Oral | Dapsone Tablets, USP 25 mg (Rising Pharmaceuticals, USA) | 245.13Schedule 2after:757 | Dapsone | Tablet 50 mg | Oral | DAPSOMED | 283.44insert:757A | Deferasirox | Tablet 90 mg | Oral | DEFERAMED | 9.17757B | Deferasirox | Tablet 90 mg | Oral | DEFERASIROX-TEVA | 9.17757C | Deferasirox | Tablet 90 mg | Oral | Deferasirox ARX | 9.17757D | Deferasirox | Tablet 90 mg | Oral | Deferasirox Sandoz | 9.17757E | Deferasirox | Tablet 90 mg | Oral | Eferas | 9.17757F | Deferasirox | Tablet 90 mg | Oral | Jadenu | 9.17757G | Deferasirox | Tablet 90 mg | Oral | Pharmacor Deferasirox FC | 9.17757H | Deferasirox | Tablet 180 mg | Oral | DEFERAMED | 18.34757I | Deferasirox | Tablet 180 mg | Oral | DEFERASIROX-TEVA | 18.34757J | Deferasirox | Tablet 180 mg | Oral | Deferasirox ARX | 18.34757K | Deferasirox | Tablet 180 mg | Oral | Deferasirox Sandoz | 18.34757L | Deferasirox | Tablet 180 mg | Oral | Eferas | 18.34757M | Deferasirox | Tablet 180 mg | Oral | Jadenu | 18.34757N | Deferasirox | Tablet 180 mg | Oral | Pharmacor Deferasirox FC | 18.34757O | Deferasirox | Tablet 360 mg | Oral | DEFERAMED | 36.68757P | Deferasirox | Tablet 360 mg | Oral | DEFERASIROX-TEVA | 36.68757Q | Deferasirox | Tablet 360 mg | Oral | Deferasirox ARX | 36.68757R | Deferasirox | Tablet 360 mg | Oral | Deferasirox Sandoz | 36.68757S | Deferasirox | Tablet 360 mg | Oral | Eferas | 36.68757T | Deferasirox | Tablet 360 mg | Oral | Jadenu | 36.68757U | Deferasirox | Tablet 360 mg | Oral | Pharmacor Deferasirox FC | 36.68Schedule 2after:1044 | Estradiol | Transdermal patches 390 micrograms, 8 | Transdermal | Estradot 25 | 16.29insert:1044A | Estradiol | Transdermal patches 390 micrograms, 8 (s19A) | Transdermal | Dermestril 25 (Italy) | 71.7Schedule 2insert:1048 | Estradiol | Transdermal patches 780 micrograms, 8 | Transdermal | Estradot 50 | 15.32after:1048A | Estradiol | Transdermal patches 780 micrograms, 8 (s19A) | Transdermal | Dermestril 50 (Italy) | 84.38Schedule 2after:1342 | Fosinopril | Tablet containing fosinopril sodium 20 mg | Oral | Monace 20 | 6.24insert:1342A | Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | FULVESTRANT ACCORD | 113.821342B | Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | FULVESTRANT EVER PHARMA | 113.821342C | Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | FULVESTRANT-AFT | 113.821342D | Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | Fulvestrant SXP | 113.821342E | Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | Fulvestrant Sandoz | 113.82Schedule 2after:1589 | Lacosamide | Oral solution 10 mg per mL, 200 mL | Oral | Vimpat | 51.71insert:1589A | Lacosamide | Tablet 100 mg | Oral | Lacosam | 9.731589B | Lacosamide | Tablet 100 mg | Oral | Lacosamide ARX | 9.731589C | Lacosamide | Tablet 100 mg | Oral | Lacosamide Lupin | 9.731589D | Lacosamide | Tablet 100 mg | Oral | Lacosamide Sandoz | 9.731589E | Lacosamide | Tablet 100 mg | Oral | Lacosamide Sandoz | 9.731589F | Lacosamide | Tablet 100 mg | Oral | Vimcosa | 9.731589G | Lacosamide | Tablet 100 mg | Oral | Vimcosa | 9.731589H | Lacosamide | Tablet 100 mg | Oral | Vimpat | 9.731589I | Lacosamide | Tablet 100 mg | Oral | Vimpat | 9.731589J | Lacosamide | Tablet 150 mg | Oral | Lacosam | 14.591589K | Lacosamide | Tablet 150 mg | Oral | Lacosamide ARX | 14.591589L | Lacosamide | Tablet 150 mg | Oral | Lacosamide Lupin | 14.591589M | Lacosamide | Tablet 150 mg | Oral | Lacosamide Sandoz | 14.591589N | Lacosamide | Tablet 150 mg | Oral | Vimcosa | 14.591589O | Lacosamide | Tablet 150 mg | Oral | Vimcosa | 14.591589P | Lacosamide | Tablet 150 mg | Oral | Vimpat | 14.591589Q | Lacosamide | Tablet 150 mg | Oral | Vimpat | 14.591589R | Lacosamide | Tablet 200 mg | Oral | Lacosam | 77.81589S | Lacosamide | Tablet 200 mg | Oral | Lacosamide ARX | 77.81589T | Lacosamide | Tablet 200 mg | Oral | Lacosamide Lupin | 77.81589U | Lacosamide | Tablet 200 mg | Oral | Lacosamide Sandoz | 77.81589V | Lacosamide | Tablet 200 mg | Oral | Vimcosa | 77.81589W | Lacosamide | Tablet 200 mg | Oral | Vimpat | 77.81589X | Lacosamide | Tablet 50 mg | Oral | Lacosam | 4.861589Y | Lacosamide | Tablet 50 mg | Oral | Lacosamide ARX | 4.861589Z | Lacosamide | Tablet 50 mg | Oral | Lacosamide Lupin | 4.861589ZA | Lacosamide | Tablet 50 mg | Oral | Lacosamide Sandoz | 4.861589ZB | Lacosamide | Tablet 50 mg | Oral | Vimcosa | 4.861589ZC | Lacosamide | Tablet 50 mg | Oral | Vimpat | 4.86Schedule 2after:1654 | Latanoprost | Eye drops 50 micrograms per mL, 2.5 mL | Application to the eye | Xalatan | 4.00insert:1654A | Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | APO-Latanoprost/Timolol 0.05/5 | 5.961654B | Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | Xalacom | 5.961654C | Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | Xalamol 50/5 | 5.96Schedule 2after:1936 | Methadone | Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 200 mL bottle, 1 mL | Oral | Biodone Forte | 7.83insert:1936A | Methadone | Tablet containing methadone hydrochloride 5 mg | Oral | METHADONE-AFT | 3.03Schedule 2after:3081 | Sitagliptin | Tablet 50 mg | Oral | Xelevia | 16.25insert:3081A | Sitagliptin with metformin | Tablet (modified release) containing 100 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Janumet XR | 23.093081B | Sitagliptin with metformin | Tablet (modified release) containing 100 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Sandoz XR | 23.093081C | Sitagliptin with metformin | Tablet (modified release) containing 100 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Sitagliptin/Metformin XR Mylan | 23.093081D | Sitagliptin with metformin | Tablet (modified release) containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Janumet XR | 23.863081E | Sitagliptin with metformin | Tablet (modified release) containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Sandoz XR | 23.863081F | Sitagliptin with metformin | Tablet (modified release) containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Sitagliptin/Metformin XR Mylan | 23.863081G | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Janumet | 16.693081H | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | SITAGLIPTIN/METFORMIN 50/1000 SUN | 16.693081I | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | SITAGLO-MET | 16.693081J | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Mylan 50/1000 | 16.693081K | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Sandoz | 16.693081L | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Velmetia | 16.693081M | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride | Oral | Janumet | 15.923081N | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride | Oral | SITAGLIPTIN/METFORMIN 50/500 SUN | 15.923081O | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride | Oral | SITAGLO-MET | 15.923081P | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Mylan 50/500 | 15.923081Q | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Sandoz | 15.923081R | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride | Oral | Velmetia | 15.923081S | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride | Oral | Janumet | 16.463081T | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride | Oral | SITAGLIPTIN/METFORMIN 50/850 SUN | 16.463081U | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride | Oral | SITAGLO-MET | 16.463081V | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Mylan 50/850 | 16.463081W | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride | Oral | Sitagliptin/Metformin Sandoz | 16.463081X | Sitagliptin with metformin | Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride | Oral | Velmetia | 16.46Schedule 2after:3151 | Tacrolimus | Capsule 0.5 mg | Oral | Tacrolimus Sandoz | 43.45insert:3151A | Tacrolimus | Capsule 0.5 mg (once daily prolonged release) | Oral | ADVAGRAF XL | 31.673151B | Tacrolimus | Capsule 0.5 mg (once daily prolonged release) | Oral | Tacrolimus XR Sandoz | 31.67Schedule 2after:3418 | Valaciclovir | Tablet 500 mg (as hydrochloride) | Oral | Zelitrex | 4.00insert:3418A | Valganciclovir | Tablet 450 mg (as hydrochloride) | Oral | Valganciclovir Sandoz | 195.353418B | Valganciclovir | Tablet 450 mg (as hydrochloride) | Oral | Valganciclovir Viatris | 195.35Schedule 2after:3449 | Vancomycin | Powder for injection 500 mg (500,000 I.U.) (as hydrochloride) | Injection | Vancomycin Viatris | 4.00insert:3449A | Vancomycin | Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) | Injection | VANCOMYCIN MEDSURGE | 4.953449B | Vancomycin | Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) | Injection | Vancomycin Juno | 4.953449C | Vancomycin | Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) | Injection | Vancomycin Viatris | 4.95Schedule 2after:3453 | Vancomycin | Capsule 250 mg (250,000 I.U.) (as hydrochloride) | Oral | Vancomycin BNM 250mg | 79.67insert:3453A | Varenicline | Box containing 11 tablets 0.5 mg and 42 tablets 1 mg | Oral | Champix | 31.923453B | Varenicline | Box containing 11 tablets 0.5 mg and 42 tablets 1 mg | Oral | PHARMACOR VARENICLINE | 31.923453C | Varenicline | Box containing 11 tablets 0.5 mg and 42 tablets 1 mg | Oral | VARENAPIX | 31.923453D | Varenicline | Box containing 11 tablets 0.5 mg and 42 tablets 1 mg | Oral | Varenicline Lupin | 31.923453E | Varenicline | Box containing 11 tablets 0.5 mg and 42 tablets 1 mg | Oral | Varenicline Sandoz | 31.923453F | Varenicline | Box containing 11 tablets 0.5 mg and 42 tablets 1 mg | Oral | Varenicline Viatris | 31.923453G | Varenicline | Tablet 1 mg | Oral | Champix | 37.633453H | Varenicline | Tablet 1 mg | Oral | PHARMACOR VARENICLINE | 37.633453I | Varenicline | Tablet 1 mg | Oral | VARENAPIX | 37.633453J | Varenicline | Tablet 1 mg | Oral | Varenicline Lupin | 37.633453K | Varenicline | Tablet 1 mg | Oral | Varenicline Sandoz | 37.633453L | Varenicline | Tablet 1 mg | Oral | Varenicline Viatris | 37.63

Sourced from the Federal Register of Legislation at legislation.gov.au, © Commonwealth of Australia, licensed under CC BY 4.0. Compilations may have been reformatted.

Contents

PB 97 of 2026
National Health (Weighted average disclosed price – October 2026 reduction day) Amendment Determination 2026
1 Name of Instrument
2 Commencement
3 Authority
4 Schedules

Contents

PB 97 of 2026
National Health (Weighted average disclosed price – October 2026 reduction day) Amendment Determination 2026
1 Name of Instrument
2 Commencement
3 Authority
4 Schedules